# Smith & Wesson Brands, Inc.: overview

SWBI · Nasdaq · CIK 1092796 · [Industrials](/sectors/industrials.md) · fiscal year ends Apr 30

Pages: [Overview](/companies/swbi.md) · [Financials](/companies/swbi/financials.md) · [Filings](/companies/swbi/filings.md) · [Insiders](/companies/swbi/insiders.md)

Latest reported revenue: [$112.6m](/filings/0001193125-26-381911.md) for Q1 FY2027, three months to 2026-07-31, from the 10-Q filed Sep 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-381911).

## Last eight quarters

| Line item | Unit | Q2 FY2025 (2024-10-31) | Q3 FY2025 (2025-01-31) | Q4 FY2025 (2025-04-30) | Q1 FY2026 (2025-07-31) | Q2 FY2026 (2025-10-31) | Q3 FY2026 (2026-01-31) | Q4 FY2026 (2026-04-30) | Q1 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [130](/filings/0001193125-25-308093.md) | [116](/filings/0001193125-26-093991.md) | [141 d](/filings/0001193125-26-274254.md) | [85.1](/filings/0001193125-26-381911.md) | [125](/filings/0001193125-25-308093.md) | [136](/filings/0001193125-26-093991.md) | [178 d](/filings/0001193125-26-274254.md) | [113](/filings/0001193125-26-381911.md) |
| Gross margin | % | [26.6%](/filings/0001193125-25-308093.md) | [24.1%](/filings/0001193125-26-093991.md) | [28.8% d](/filings/0001193125-26-274254.md) | [25.9%](/filings/0001193125-26-381911.md) | [24.3%](/filings/0001193125-25-308093.md) | [26.2%](/filings/0001193125-26-093991.md) | [29.8% d](/filings/0001193125-26-274254.md) | [28.7%](/filings/0001193125-26-381911.md) |
| Operating margin | % | [5.8%](/filings/0001193125-25-308093.md) | [4.1%](/filings/0001193125-26-093991.md) | [9.3% d](/filings/0001193125-26-274254.md) | [(3.5%)](/filings/0001193125-26-381911.md) | [3.3%](/filings/0001193125-25-308093.md) | [4.9%](/filings/0001193125-26-093991.md) | [12.0% d](/filings/0001193125-26-274254.md) | [3.7%](/filings/0001193125-26-381911.md) |
| Net margin | % | [3.5%](/filings/0001193125-25-308093.md) | [1.8%](/filings/0001193125-26-093991.md) | [6.1% d](/filings/0001193125-26-274254.md) | [(4.0%)](/filings/0001193125-26-381911.md) | [1.5%](/filings/0001193125-25-308093.md) | [2.8%](/filings/0001193125-26-093991.md) | [9.1% d](/filings/0001193125-26-274254.md) | [2.3%](/filings/0001193125-26-381911.md) |
| Diluted EPS | $ per share | [0.10](/filings/0001193125-25-308093.md) | [0.05](/filings/0001193125-26-093991.md) | not reported | [(0.08)](/filings/0001193125-26-381911.md) | [0.04](/filings/0001193125-25-308093.md) | [0.08](/filings/0001193125-26-093991.md) | not reported | [0.06](/filings/0001193125-26-381911.md) |
| Free cash flow | $m | [(10.7) d](/filings/0001193125-25-308093.md) | [(16.1) d](/filings/0001193125-26-093991.md) | [33.5 d](/filings/0001193125-26-274254.md) | [(12.4)](/filings/0001193125-26-381911.md) | [16.3 d](/filings/0001193125-25-308093.md) | [16.8 d](/filings/0001193125-26-093991.md) | [69.7 d](/filings/0001193125-26-274254.md) | [(20.8)](/filings/0001193125-26-381911.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-04-30) | FY2023 (2023-04-30) | FY2024 (2024-04-30) | FY2025 (2025-04-30) | FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [864](/filings/0000950170-24-075584.md) | [479](/filings/0000950170-25-088157.md) | [536](/filings/0001193125-26-274254.md) | [475](/filings/0001193125-26-274254.md) | [524](/filings/0001193125-26-274254.md) |
| Gross margin | % | [43.3%](/filings/0000950170-24-075584.md) | [32.2%](/filings/0000950170-25-088157.md) | [29.5%](/filings/0001193125-26-274254.md) | [26.8%](/filings/0001193125-26-274254.md) | [26.9%](/filings/0001193125-26-274254.md) |
| Operating margin | % | [29.1%](/filings/0000950170-24-075584.md) | [10.1%](/filings/0000950170-25-088157.md) | [8.8%](/filings/0001193125-26-274254.md) | [5.0%](/filings/0001193125-26-274254.md) | [5.6%](/filings/0001193125-26-274254.md) |
| Net margin | % | [22.5%](/filings/0000950170-24-075584.md) | [7.7%](/filings/0000950170-25-088157.md) | [7.7%](/filings/0001193125-26-274254.md) | [2.8%](/filings/0001193125-26-274254.md) | [3.5%](/filings/0001193125-26-274254.md) |
| Diluted EPS | $ per share | [4.08](/filings/0000950170-24-075584.md) | [0.80](/filings/0000950170-25-088157.md) | [0.89](/filings/0001193125-26-274254.md) | [0.30](/filings/0001193125-26-274254.md) | [0.41](/filings/0001193125-26-274254.md) |
| Free cash flow | $m | [114](/filings/0000950170-24-075584.md) | [(72.8)](/filings/0000950170-25-088157.md) | [16.0](/filings/0001193125-26-274254.md) | [(28.8)](/filings/0001193125-26-274254.md) | [90.4](/filings/0001193125-26-274254.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/swbi/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $61.5m | 4,092,378 |  | Added +158,154 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $40.3m | 2,678,761 |  | Added +62,442 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $33.4m | 2,218,774 |  | Added +68,700 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $28.6m | 1,899,225 |  | Added +42,345 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $26.5m | 1,760,476 |  | Added +102,510 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $19.8m | 1,316,636 |  | Added +205,392 |
| [CHARLES SCHWAB INVESTMENT MANAGEMENT INC](/funds/884546.md) | 2026-06-30 | $14.9m | 993,640 |  | Reduced −214,154 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $14.7m | 975,573 |  | Added +442,412 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $14.1m | 936,604 |  | Added +98,231 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $12.9m | 854,960 |  | Added +489,966 |

## Recent filings

[All 1,212 filings](/companies/swbi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-28 | 17:53 ET | [SCHEDULE 13D](/filings/0001493152-26-049116.md) | Ownership report, active investor | 0001493152-26-049116 |
| 2026-10-21 | 09:05 ET | [8-K](/filings/0001193125-26-427316.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-427316 |
| 2026-09-16 | 16:17 ET | [8-K](/filings/0001193125-26-393097.md) | 5.07 Shareholder vote results | 0001193125-26-393097 |
| 2026-09-03 | 16:15 ET | [10-Q](/filings/0001193125-26-381911.md) | Quarterly report, period 2026-07-31 | 0001193125-26-381911 |
| 2026-09-03 | 16:15 ET | [8-K](/filings/0001193125-26-381907.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-381907 |
| 2026-08-06 | 17:16 ET | [DEF 14A](/filings/0001193125-26-338441.md) | Proxy statement, period 2026-09-15 | 0001193125-26-338441 |
| 2026-07-15 | 06:50 ET | [8-K](/filings/0001193125-26-304020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-304020 |
| 2026-06-17 | 16:36 ET | [10-K](/filings/0001193125-26-274254.md) | Annual report, period 2026-04-30 | 0001193125-26-274254 |
| 2026-06-17 | 16:05 ET | [8-K](/filings/0001193125-26-274138.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-274138 |
| 2026-03-05 | 16:15 ET | [10-Q](/filings/0001193125-26-093991.md) | Quarterly report, period 2026-01-31 | 0001193125-26-093991 |

## Latest annual report

[Form 10-K for the fiscal year ended Apr 30, 2026](/filings/0001193125-26-274254.md), filed Jun 17, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1092796
- Tickers: SWBI
- Exchange: Nasdaq
- SIC code: 3480 Ordnance & Accessories, (No Vehicles/Guided Missiles)
- State of incorporation: NV
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:31 ET. No prices; not investment advice.